Missense mutations (p.H371Y, p.D438Y) in gene CHEK2 are associated with breast cancer risk in women of Balochistan origin

Various Aspects, Patterns and Risk Factors in Breast Cancer Patients of Balochistan

(2013) Abdul Hameed Baloch et al.   Asian Pacific Journal of Cancer Prevention

Detection ofBRCA1/2mutations in breast cancer patients from Thailand and Pakistan

(2012) J Ahmad et al.   CLINICAL GENETICS

Detecting differential allelic expression using high-resolution melting curve analysis: application to the breast cancer susceptibility gene CHEK2

(2011) Tú Nguyen-Dumont et al.   BMC Medical Genomics

A recurrent CHEK2 p.H371Y mutation is associated with breast cancer risk in Chinese women

(2011) Yin Liu et al.   HUMAN MUTATION

Family History, Genetic Testing, and Clinical Risk Prediction: Pooled Analysis of CHEK2*1100delC in 1,828 Bilateral Breast Cancers and 7,030 Controls

(2009) O. Fletcher et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Structure and Activation Mechanism of the CHK2 DNA Damage Checkpoint Kinase

(2009) Zhenjian Cai et al.   MOLECULAR CELL

Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women

(2009) Rowan T. Chlebowski et al.   NEW ENGLAND JOURNAL OF MEDICINE

Identification of a novel CHEK2variant and assessment of its contribution to the risk of breast cancer in French Canadian women

(2008) David J Novak et al.   BMC CANCER

CHEK2*1100delC Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26,000 Patient Cases and 27,000 Controls

(2008) Maren Weischer et al.   JOURNAL OF CLINICAL ONCOLOGY